Mendelics logo — Análise genômica ao alcance de todos

Mendelics

Análise genômica ao alcance de todos

Founded 2012 Brazil Brazil 154 employees Biotechnology, Health Care

General Information

Company Name Mendelics
Founded Year 2012
Location Brazil Brazil
Employees 154
Industries Biotechnology, Health Care
Business Model B2B, B2C, B2D
Revenue Model Service Fee, Transaction Fee, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with Mendelics. To contact Mendelics, visit mendelics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Mendelics

Mendelics, founded in 2012, stands at the forefront of the Biotechnology and Health Care industries, with its headquarters based in Brazil. The company operates under the compelling slogan, "Análise genômica ao alcance de todos," which translates to making genomic analysis accessible to all. This reflects their commitment to democratizing genetic diagnostics.

Specializing in genomic interpretation, Mendelics leverages advanced exoma analysis to assist medical professionals in diagnosing genetic diseases that were once challenging to identify. By providing rapid and precise genetic diagnostics, the company enhances practical medical applications based on human genome knowledge.

Although there is no recent investment activity recorded, the potential for growth remains significant. As an innovator in making genetic diagnostics more accessible, Mendelics presents a potentially lucrative opportunity for investors, poised to meet increasing demands in personalized healthcare solutions.

Taxonomy: genomic analysis, genetic diagnostics, exome sequencing, medical genomics, disease diagnosis, genomic interpretation, precision medicine, genetic testing, personalized medicine, clinical genomics

Services & Products

Exome Sequencing
Cancer Genetic Testing
Pediatric Genetic Screenings
Carrier Screening for Recessive Diseases
Customized Genetic Sequencing
Genotype Analysis

Target Customers

Healthcare Providers Medical Institutions Oncologists Geneticists Patients seeking genetic insights Healthcare Research Organizations

No funding data available for Mendelics yet.

Mendelics Alternatives & Competitors

Mendelics vs
CENTOGENE
CENTOGENE Germany

Empowering precision medicine through advanced diagnosis 

IPO
475 employees
Biotechnology, Health Care
Mendelics vs
Ashion Analytics
Ashion Analytics United States

We are an Exact Sciences sequencing-based Clinical laboratory. We tap into the power of the human ge...

3 employees
Biotechnology, Health Care
Mendelics vs
Congenica
Congenica United Kingdom

Driving Precision Medicine

Series C
24 employees
Biotechnology, Health Care
Also compare with: Mendelics vs Helix Helix

FAQ About Mendelics

Análise genômica ao alcance de todos
Mendelics was founded in 2012.
Mendelics is headquartered in Brazil.
Mendelics operates in Biotechnology and Health Care. Its work centres on genomic analysis, genetic diagnostics, exome sequencing and medical genomics. Its customers include Healthcare Providers, Medical Institutions and Oncologists.
Mendelics has a B2B, B2C and B2D business model. Its revenue comes from Service Fee, Transaction Fee and Product Sales.
Mendelics has approximately 154 employees.
Mendelics offers: Exome Sequencing, Cancer Genetic Testing, Pediatric Genetic Screenings, Carrier Screening for Recessive Diseases, Customized Genetic Sequencing, Genotype Analysis.
Top alternatives and competitors to Mendelics include CENTOGENE, Ashion Analytics, Congenica, Dhiti Omics, Helix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mendelics and CENTOGENE are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mendelics, https://bouncewatch.com/company/mendelics, updated 30 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes